A detailed history of Israel Englander (Millennium Management LLC) transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Millennium Management LLC holds 236,073 shares of ARCT stock, worth $3.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
236,073
Previous 555,024 57.47%
Holding current value
$3.99 Million
Previous $13.5 Million 59.46%
% of portfolio
0.0%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.08 - $25.38 $5.77 Million - $8.09 Million
-318,951 Reduced 57.47%
236,073 $5.48 Million
Q2 2024

Aug 14, 2024

BUY
$24.35 - $44.39 $9.65 Million - $17.6 Million
396,505 Added 250.13%
555,024 $13.5 Million
Q1 2024

May 15, 2024

BUY
$31.23 - $42.99 $776,346 - $1.07 Million
24,859 Added 18.6%
158,519 $5.35 Million
Q4 2023

Feb 14, 2024

BUY
$17.71 - $32.97 $2.16 Million - $4.02 Million
121,896 Added 1036.18%
133,660 $4.21 Million
Q2 2023

Aug 14, 2023

SELL
$23.94 - $32.36 $2.19 Million - $2.97 Million
-91,647 Reduced 88.62%
11,764 $337,000
Q1 2023

May 15, 2023

BUY
$14.72 - $23.97 $912,993 - $1.49 Million
62,024 Added 149.86%
103,411 $2.48 Million
Q4 2022

Feb 14, 2023

BUY
$14.14 - $23.06 $324,173 - $528,673
22,926 Added 124.19%
41,387 $702,000
Q3 2022

Nov 14, 2022

SELL
$13.05 - $22.13 $2.43 Million - $4.12 Million
-186,135 Reduced 90.98%
18,461 $274,000
Q2 2022

Aug 15, 2022

BUY
$12.26 - $31.17 $2.51 Million - $6.38 Million
204,596 New
204,596 $3.22 Million
Q4 2021

Feb 14, 2022

SELL
$34.2 - $47.56 $3.05 Million - $4.24 Million
-89,075 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$27.88 - $58.25 $2.48 Million - $5.19 Million
89,075 New
89,075 $4.26 Million
Q2 2021

Aug 16, 2021

SELL
$25.79 - $42.11 $2.71 Million - $4.43 Million
-105,138 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$38.75 - $86.92 $2.88 Million - $6.46 Million
74,273 Added 240.64%
105,138 $4.34 Million
Q4 2020

Feb 16, 2021

BUY
$34.61 - $123.66 $1.07 Million - $3.82 Million
30,865 New
30,865 $1.34 Million
Q3 2020

Nov 16, 2020

SELL
$37.49 - $63.19 $235,287 - $396,580
-6,276 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$12.66 - $58.27 $1.19 Million - $5.48 Million
-94,000 Reduced 93.74%
6,276 $293,000
Q1 2020

May 14, 2020

BUY
$9.31 - $18.26 $933,569 - $1.83 Million
100,276 New
100,276 $1.36 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $449M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.